Mesenchymal Precursor Cells
AssetCell therapyAlso MPCs
Allogeneic mesenchymal precursor cells promoting tissue repair and reducing inflammation
- Stage
- Phase 2
- Modality
- Cell therapy
- Target
- Inflammation
- Indications
- 4
- Trials
- 4
- Developers
- 1
Indications
4Degenerative disc disease
Phase 2COMPLETEDNCT01290367clinicaltrials.gov7 Oct 2026
Heart failure
Phase 2COMPLETEDNCT00721045clinicaltrials.gov7 Oct 2026
Diabetic nephropathy
Phase 1COMPLETEDNCT01843387clinicaltrials.gov7 Oct 2026
1 more
- Targets and what it contains2
- Owner and partners1
- Trials4
- Evidence for its targets2
- Competitors12
- Aging relevance2
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 4 sources